Literature DB >> 21824682

Epidemiology of central line-associated bloodstream infections in Quebec intensive care units: a 6-year review.

Patricia S Fontela1, Robert W Platt, Isabelle Rocher, Charles Frenette, Dorothy Moore, Elise Fortin, David Buckeridge, Madukhar Pai, Caroline Quach.   

Abstract

BACKGROUND: The burden of central line-associated bloodstream infections (CLABSI) in Canadian intensive care units (ICUs) is not well established. The present study aimed to describe CLABSI epidemiology in Quebec ICUs during 2003-2009.
METHODS: The study population was a retrospective dynamic cohort of 58 ICUs that participated in the Surveillance Provinciale des Infections Nosocomiales program during 2003-2009. We calculated annual CLABSI incidence rates (IRs), central venous catheter (CVC) utilization ratios, and case-fatality proportions, and described the pathogens involved. We analyzed data using descriptive statistics and standardized incidence ratios.
RESULTS: A total of 891 CLABSIs were identified during 446,137 CVC-days. In 2003-2009, CLABSI IRs were 1.67 CLABSI/1,000 CVC-days in adult ICUs, 2.20 CLABSIs/1,000 CVC-days in pediatric ICUs, and 4.40 CLABSIs/1,000 CVC-days in neonatal ICUs. Since 2007, CLABSI IRs in adult, pediatric and neonatal ICUs have decreased by 11%, 50%, and 18%, respectively. Pediatric ICUs had the highest CVC utilization ratio (median, 0.61; interquartile range, 0.57-0.66). Coagulase-negative staphylococci caused 53% of the CLABSIs. The proportion of methicillin-resistant Staphylococcus aureus declined from 70% to <40% after 2006.
CONCLUSIONS: CLABSIs result in a considerable burden of illness in Quebec ICUs. However, CLABSI IRs have decreased since 2007, and the proportion of methicillin-resistant S aureus has remained <40% since 2006. Continuous surveillance is essential to determine whether these changes are sustainable.
Copyright © 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21824682     DOI: 10.1016/j.ajic.2011.04.008

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

1.  Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.

Authors:  Ricardo Silveira Yamaguchi; Danilo Teixeira Noritomi; Natalia Viu Degaspare; Gabriela Ortega Cisternas Muñoz; Ana Paula Matos Porto; Silvia Figueiredo Costa; Otavio T Ranzani
Journal:  Intensive Care Med       Date:  2017-06-05       Impact factor: 17.440

2.  Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are Chosen.

Authors:  Thomas L Holland
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

3.  A quality assurance investigation of CLABSI events: are there exceptions to never?

Authors:  Samantha Strickler; Rohit R Gupta; John T Doucette; Roopa Kohli-Seth
Journal:  J Infect Prev       Date:  2017-07-28

4.  'Matching Michigan': a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England.

Authors:  Julian Bion; Annette Richardson; Peter Hibbert; Jeanette Beer; Tracy Abrusci; Martin McCutcheon; Jane Cassidy; Jane Eddleston; Kevin Gunning; Geoff Bellingan; Mark Patten; David Harrison
Journal:  BMJ Qual Saf       Date:  2012-09-20       Impact factor: 7.035

5.  Central line associated blood stream infection rate after intervention and comparing outcome with national healthcare safety network and international nosocomial infection control consortium data.

Authors:  Sz Bukhari; A Banjar; Ss Baghdadi; Ba Baltow; Am Ashshi; Wm Hussain
Journal:  Ann Med Health Sci Res       Date:  2014-09

6.  Accuracy and generalizability of using automated methods for identifying adverse events from electronic health record data: a validation study protocol.

Authors:  Christian M Rochefort; David L Buckeridge; Andréanne Tanguay; Alain Biron; Frédérick D'Aragon; Shengrui Wang; Benoit Gallix; Louis Valiquette; Li-Anne Audet; Todd C Lee; Dev Jayaraman; Bruno Petrucci; Patricia Lefebvre
Journal:  BMC Health Serv Res       Date:  2017-02-16       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.